Genome sequencing study for children and young people with cancer
Part of Cancer clinical trials.
This study looks at whole genome sequencing (a complete read of your DNA) from children and young people with cancer. It aims to learn more about cancer and how it might be treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years old or younger.
- You must have been diagnosed with a neoplastic disorder (cancer or a benign tumor).
- You must have been offered NHS England whole genome sequencing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers whole-genome testing (a way to read a person’s DNA) to families after a child is newly diagnosed with cancer. It aims to find inherited changes that may explain why cancer happened and guide future care or monitoring.
This study looks at your genes to help doctors choose the safest and most effective cancer medicines for you. It is for children and young adults who are newly diagnosed and about to start treatment.
This study looks at how well a special type of gene testing (called sequencing) works for people with cancer. It aims to learn if this test helps doctors choose better treatments.
This study follows children, teens, and young adults with cancer and people who have completed treatment. It aims to better understand cancer care over time and what affects outcomes, which may help improve future treatment and follow-up.
This trial uses a rapid type of genetic testing (whole genome sequencing) to look at the DNA of children and young adults with cancer. The goal is to better understand each person's cancer and potentially guide treatment decisions.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.